New drug wafer aims to block lung Cancer's return
Disease control
Recruiting now
This study is testing a new drug called SMS001, which is a special form of the chemotherapy paclitaxel. It is being given to patients with early-stage non-small cell lung cancer right after their surgery, with the goal of preventing the cancer from coming back. Researchers will c…
Phase: PHASE2 • Sponsor: ToLymph Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC